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Direct Suppression of Stat1 Function during
Adenoviral Infection
transcription complex. In addition, p300/CBP proteins
influence gene transcription by intrinsic histone acetyl-
transferase (HAT) activity and by linking additional co-
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activators (such as p300/CBP/cointegrator-associatedand Michael J. Holtzman*²³
protein or p/CIP) to core histones (Torchia et al., 1997).*Department of Medicine
Thus, by sequestering (and perhaps linking) Rb- and²Department of Cell Biology
p300/CBP-type proteins in competition with endogenousWashington University School of Medicine
transcription factors and coactivators, three E1A do-St. Louis, Missouri 63110
mains (N terminus, conserved region 1, and conserved
region 2) are sufficient for mediating cellular proliferation
(Wang et al., 1993).Summary
In addition to altering control of the cell cycle, adeno-
viruses also aim to subvert host defense by evadingThe action of adenoviral E1A oncoprotein on host im-
immune detection. Early studies in cell lines suggestedmune-response genes has been attributed to interac-
that E1A might inhibit activation of immune-response
tion with p300/CBP-type transcriptional coactivators
genes by disrupting events (such as protein phosphory-
in competition with endogenous transcription factors lation) that lead to protein±DNA interactions at inter-
such as signal transducer and activator of transcrip- feron-responsive enhancers (Kalvakolanu et al., 1991).
tion (STAT) proteins. However, we show that mutant However, more recent studies demonstrated that E1A
forms of E1A that no longer bind p300/CBP can still capacity for immune suppression might also depend on
interact directly with Stat1 (via E1A N-terminal and targeting p300/CBP. Thus, p300/CBP coactivatorfunc-
Stat1 C-terminal residues) and block IFNg-driven, Stat1- tion was extended to c-Fos and c-Jun components of
dependent gene activation and consequent function activator protein-1 (AP-1) (Bannister and Kouzarides,
during early-phase infection in the natural host cell. 1995; Arias, 1997), the p65 component of NF-kB (Gerrit-
The results provide a distinct and more specific mech- sen et al., 1997), steroid and nuclear-hormone receptors
anism for E1A-mediated immune suppression and an (Yang et al., 1996; Kurokawa et al., 1998), and to the
alternative model of IFNg-driven enhanceosome for- first two members of the signal transducer and activator
mation that may allow for other adaptors (in addition of transcription (STAT) family (Bhattacharya et al., 1996;
to p300/CBP) to link Stat1 to the basal transcription Zhang et al., 1996; Horvai et al., 1997) that mediate IFN-
complex. driven gene activation. In all cases, including Stat1 and
Stat2, E1A influenced host gene expression by compet-
ing with these endogenous factors for binding to p300/Introduction
CBP (Bannister and Kouzarides, 1995; Yang et al., 1996;
Zhang et al., 1996; Bhattacharya et al., 1996; GerritsenImmunity to viral pathogens depends on coordinated
et al., 1997; Kurokawa et al., 1998). Since Stat1 is criticalcontrol of host cell genes, so viruses (including adenovi-
for IFNg-driven gene transcription, competition for p300/ruses) have developed strategies to redirect the normal
CBP by E1A oncoprotein may underlie its capacity togenetic program (Ploegh, 1998). As one of the most
subvert IFNg-stimulated immunity.informative examples, the adenoviral early region 1A
In reviewing previous work, we questioned whether(E1A) gene encodes for an oncoprotein that activates
E1A might also act directly on a specific DNA-bindingthe host cell cycle and enables DNA synthesis needed
transcription factor and thereby provide determinantsfor viral replication. To accomplish this, E1A oncoprotein
for more precisely influencing gene expression. Prece-presents two distinct binding sites for competing with
dent for this possibility may be found in interactions ofcell cycle regulators: one site uses conserved region 2
the transactivating domain of E1A (conserved region 3)and conserved region 1 to bind a family of anti-oncopro-
with transcription factors needed for viral gene expres-teins typified by retinoblastoma (Rb) protein; the other
sion (Liu and Green, 1994), but, at least to date, E1Asite uses N-terminal residues and conserved region 1
N terminus interactions appear more highly restrictedto bind a family of transcriptional coactivators typified
(Moran, 1994). Nonetheless, additional interactions might
by p300 (Whyte et al., 1989; Moran, 1994). The Rb protein
not be detected if E1A determinants for binding p300/
and Rb-related p107 and p130 proteins normally bind to CBP overlapped with those for binding more specific
the E2F transcription factor and silence genes needed cellular activators. In addition, previous studies of ade-
for progression through the cell cycle (Weintraub et al., noviral infection and host gene behavior often used
1995). The p300 protein (Chrivia et al., 1993) and the transformed cell lines rather than the natural adenoviral
related cAMP-response-element-binding protein (CREB)- host cell and so cannot exclude confounding effects of
binding protein (CBP) (Eckner et al., 1994) serve as adap- other oncogenes (such as SV40 large T antigen) on E1A
tor proteins that link transcription factors such as CREB action (Eckner et al., 1996).
(Kwok et al., 1994; Arias, 1997) as well as p53 anti- In that context, we have used primary culture human
oncoprotein (Gu et al., 1997; Lill et al., 1997) to the basal tracheobronchial epithelial (hTBE) cells (along with en-
dobronchial tissue and mouse models of viral bronchitis)
to define epithelial cell±dependent immunity to respira-³ To whom correspondence should be addressed (e-mail: mholtzman
@pulmonary.wustl.edu). tory pathogens (Taguchi et al., 1998; Walter et al., 1998).
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Figure 1. E1A-Dependent Inhibition of IFNg-
Inducible Expression of ICAM-1 and IRF-1
Genes during Adenoviral Infection
(A) IFNg-inducible ICAM-1-dependent T cell
adhesion to airway epithelial (hTBE) cell mono-
layers was determined by a flow cytometry±
based technique with phorbol dibutyrate
(PDB)-treated T cells and IFNg-treated mono-
layers to maximize adhesion. Adhesion was
determined after infection with no virus (NV),
wild-type adenovirus (AdV), or E1A-deficient
AdV-d312 for 8 hr before IFNg treatment for
18 hr. A significant decrease in adhesion from
treatment levels is indicated by an asterisk.
(B) IFNg-inducible ICAM-1 levels were as-
sayed using an enzyme-linked immunoassay
with hTBE cell monolayers that were left unin-
fected or were infected with AdV or AdV-d312
for the indicated times before IFNg treatment
for 18 hr. A significant decrease from IFNg-
stimulated levels is indicated by asterisks. In
(A) and (B), values are expressed as mean 6
SEM (n 5 3±5) and are representative of three
experiments.
(C) IFNg-inducible ICAM-1 mRNA levels were
determined by Northern blot analysis of total
cellular from hTBE cell monolayers that were
left uninfected or were infected with AdV or
AdV-d312 for the indicated times before IFNg
treatment for 4 hr. The position of the 3.3 kb ICAM-1, 4.4 and 2.0 kb IRF-1, and 1.35 kb GAPDH mRNAs are indicated by arrows.
(D) IFNg-inducible HLA-A,B levels were determined using anti-HLA-A,B MAb and the protocol described in (B) with AdV or AdV-d312 infection
for 8 hr before IFNg treatment.
Our work on isolated cells indicates that a subset of E1A N terminus in mediating immune suppression, and
a revised model of Stat1-dependent gene expression.epithelial immune-response genes typified by intercellu-
lar adhesion molecule-1 (ICAM-1) are controlled by an
IFNg-responsive Janus family kinase (Jak)-STAT signal-
ing pathway that relies on Stat1 to first be phosphory- Results
lated at the IFNg receptor complex and then to bind to
an 11 bp inverted repeat in the ICAM-1 promoter region AdV Depends on E1A to Rapidly Inhibit
IFNg-Inducible Gene Expression(Look et al., 1994, 1995; Walter et al., 1997). At the pro-
moter, Stat1 interacts with adjacent transcription factors Initial experiments indicated that AdV infection (begin-
ning 8 hr before cytokine treatment) blocked subsequentsuch as specificity protein 1 (Sp1) and with p300/CBP
(Look et al., 1995; Zhang et al., 1996; Horvai et al., 1997) IFNg-dependent T cell adhesion to airway epithelial cells,
and this blockade depended on E1A expression (Figureto facilitate enhanceosome formation and induce gene
transcription. As noted above, E1A±p300/CBP interac- 1A). AdV infection for this duration had no effect on cell
viability (data not shown), suggesting a specific adenovi-tion may therefore underlie its capacity to subvert IFNg-
driven gene activation or, alternatively, may explain the ral effect on cell adhesion molecule expression. Be-
cause ICAM-1 is required for epithelial±T cell adhesionantiviral effect of IFNg (Zhang et al., 1996).
In this report, however, we demonstrate that E1A can (Nakajima et al., 1994, 1995; Taguchi et al., 1998), we
determined the effect of AdV infection on ICAM-1 levels.also modify Stat1-dependent gene activation by direct
action on Stat1 itself. Using mutant forms of E1A, we AdV infection had no effect on basal ICAM-1 levels but
rapidly (4±8 hr of infection before cytokine treatment)define an N terminus determinant (Arg2) for binding p300/
CBP that is not needed for binding Stat1. Furthermore, blocked subsequent IFNg induction of ICAM-1 protein
and mRNA (Figures 1B and 1C). This effect was againwe show that mutant E1A with no capacity for binding
p300 or inhibiting p300/CBP-dependent events (Whyte dependent on E1A expression, and the same pattern of
E1A-dependent blockade was found for IFNg inductionet al., 1989; Wang et al., 1993; Lee et al., 1996) still binds
Stat1 and inhibits IFNg-induced, Stat1-dependent trans- of IRF-1 (Figure 1C) and MHC class I genes (Figure 1D).
Each of these genes (ICAM-1, IRF-1, and MHC class I)activation of exogenous and endogenous target genes
early in the course of adenoviral infection. This effect is belongs to a subset of epithelial immune-response
genes under the control of an IFNg-driven JAK/STATdistinct from downregulation of Stat1 phosphorylation
that occurs later in the course of infection. Taken to- signaling pathway (Holtzman et al., 1998), so subse-
quent experiments were directed at determining E1A-gether, these results provide for an overall scheme for
adenoviral disruption of host gene expression during dependent mechanisms for modifying this pathway for
controlling gene expression.early- and late-phase infection, a novel action of the
Stat1 and Adenovirus
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Early AdV Infection Specifically Blocks
IFNg-Inducible Gene Transcription
but Not Stat1 Activation
Because IFNg-driven Jak/STAT-dependent induction of
ICAM-1 and IRF-1 gene expression depends on in-
creased gene transcription (Sims et al., 1993; Look et
al., 1994), we first determined the effect of AdV infection
on the level of nascent mRNA transcripts. Nuclear runoff
assays indicated that AdV infection (for 8 hr) did not
cause a general downregulation of transcription (Figure
2A), but completely inhibited IFNg-dependent increases
in ICAM-1 and IRF-1 gene transcription (Figure 2B). Be-
cause activated Stat1 is required for IFNg-driven tran-
scription of the ICAM-1 and IRF-1 genes (Walter et al.,
1997), we next determined if AdV infection influences
Stat1 phosphorylation required for Stat1 activity. West-
ern blotting indicated that AdV infection for 24 hr inhib-
ited IFNg-dependent phosphorylation of Stat1 (Figure
2C), and this effect may account for the block in IFNg-
induced gene transcription during late-phase infection.
However, infection with AdV for 8±12 hr did not sig-
nificantly affect Stat1 phosphorylation. Because IFNg-
induced Stat1 phosphorylation remains intact during
early-phase adenoviral infection despite downregulation
of Stat1-dependent gene transcription, we examined
events downstream to Stat1 phosphorylation (i.e., nu-
clear translocation and DNA binding) that are required
for Stat1-dependent gene transcription. Using immuno-
fluorescence cytochemistry to assess nuclear translo-
cation, we found that Stat1 translocation is not affected
during the early phase of adenoviral infection, in contrast
Figure 2. Blockade of IFNg-Inducible Gene Transcription but Not
to the expected block in translocation during late-phase Stat1 Phosphorylation during Early Adenoviral Infection
infection (Figure 3A). Similarly, gel mobility shift assays (A) Levels of transcription in hTBE cell monolayers that were unin-
indicated that IFNg-induced binding of Stat1 to the ICAM-1 fected (NV) or infected with AdV for 8 hr was assessed by nuclear
gene IFNg-response element (as well as constitutive runoff assay. Arrows indicate 32P-labeled transcripts that hybridized
with immobilized vector alone or vector containing b1-integrin,binding of Sp1 to the IRE and CREB binding to the cyclic
a-actin, GAPDH, E1A, TTF-1, p65, and Rel cDNAs.AMP response element) are unaffected by early-phase
(B) IFNg-inducible levels of transcription was then assessed by nu-AdV infection (Figure 3B). Taken together, the results
clear runoff assays in hTBE cell monolayers uninfected or infected
indicate that the early phase of adenoviral infection de- with AdV for 8 or 24 hr and left untreated or treated with IFNg for
pends on E1A itself or E1A-dependent events to block 3 hr. Arrows indicate transcripts hybridizing with immobilized vector
Stat1-dependent transcription by interfering with events alone or vector containing ICAM-1, IRF-1, E1A, and Alu repeat se-
quence cDNAs.downstream to Stat1 binding at the gene promoter.
(C) Stat1 phosphorylation was assessed by immunoblot analysis of
hTBE cell monolayers uninfected or infected with AdV for 4±24 hr
and then left untreated or treated with IFNg for 1 hr. Cell lysates fromAdenoviral E1A Oncoprotein Interacts
each condition were subjected to SDS-PAGE and electrophoreticDirectly with Stat1
transfer to a PVDF membrane for immunoblotting against anti-Stat1
As noted above, other reports indicate that E1A directly or E1A MAb. Identity of phosphorylated Stat1 was confirmed by
blocks IFNg-driven gene transcription at the promoter, immunoprecipitation with anti-Stat1 MAb followed by immunoblot
analysis with anti-phosphotyrosine antibody (data not shown). Cor-and our results with AdV infection demonstrate that inhi-
responding levels of ICAM-1 mRNA were assessed in duplicatebition of Stat1 function both requires and coincides with
samples using Northern blot analysis as described in Figure 1.E1A expression (Figure 2C). We therefore reasoned that
inhibition of Stat1-dependent gene transcription by
early-phase AdV infection was dependent on E1A inter-
residue region containing conserved region 3) are theaction with factor(s) required for Stat1 action at the gene
predominant splice variants produced during early-phasepromoter, and a candidate factor was p300/CBP.
adenoviral infection (Moran, 1994). Initial immunoblot-In our first set of experiments, we analyzed E1A inter-
ting experiments indicated that cellular levels of E1Aaction with endogenous p300/CBP using protein ex-
and other proteins (Sp1, p300, Rb, and Stat1) were com-tracts from hTBE cells infected with wild-type AdV or
parable in hTBE cells infected with wild-type or mutantwith AdV that expressed the 12S E1A containing N-ter-
AdV (Figure 4A), and subsequent coimmunoprecipita-minal mutations that block E1A-p300/CBP interaction
tion experiments with anti-E1A MAb indicated that E1A-(Stein et al., 1990; Wang et al., 1993). The 289 residue
13S E1A and 243 residue 12S E1A (which lacks the 46 p300/CBP interaction was present with native E1A and
Immunity
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Figure 4. Direct E1A-Stat1 Binding Detected by Endogenous Stat1
Interaction with RG2 Mutant E1A, Purified Stat1 Interaction with
Mutant and Wild-Type E1A, and Intracellular Stat1-E1A Interaction
in a Yeast Two-Hybrid System
(A) Levels of endogenous proteins in hTBE cell monolayers were
assessed by immunoblot analysis of extracts from cell monolayers
that were infected with wild-type AdV encoding 13S E1A, E1A-defi-
cient AdV (AdV-d312), wild-type AdV encoding 12S E1A, or AdV
encoding mutant 12S E1A (RG2 or d2-36) for 8 hr and then treated
with IFNg for 1 hr. For each condition, cell extracts were subjected
to SDS-PAGE and transferred to PVDF membrane for blotting
against Ab to Sp1, p300, Rb protein, Stat1, or E1A. Primary Ab
binding was detected using anti-mouse IgG- or anti-rabbit IgG-
horseradish peroxidase conjugate and an enhanced chemilumines-
Figure 3. Preservation of IFNg-Inducible Stat1 Translocation and
cence method.
DNA Binding during Early Adenoviral Infection
(B) E1A interaction with endogenous proteins were assessed in
(A) Stat1 translocation was assessed by immunofluorescence mi- immunoprecipitations using duplicate cell extracts from conditions
croscopy of hTBE cell monolayers that were uninfected (NV) or in (A). For each condition, anti-E1A Ab and protein A-Sepharose
infected with AdV for 8 or 24 hr and then left untreated or treated was mixed with cell extract to generate an immune complex that
with IFNg for 1 hr. Stat1 was detected using anti-Stat1 primary Ab was then subjected to immunoblot analysis against Ab to p300,
and FITC-conjugated secondary Ab. Concomitant immunostaining retinoblastoma protein (Rb), Stat1, or E1A. Similar results were ob-
demonstrated nuclear expression of E1A in .98% of cells (data not tained with extracts from cells that were not treated with IFNg (data
shown). Scale bar, 20 mm. not shown). Lane 1 contains extract that was immunoprecipitated
(B) Stat1 binding was assessed in gel mobility shift assays using with an isotype-matched control (Ctl) Ab.
nuclear protein extracts from hTBE cell monolayers that were unin- (C) E1A interaction with purified Stat1 was assessed by immunoaf-
fected or infected with AdV for 8 hr and then left untreated or treated finity assay using wild-type 12S E1A and 12S E1A mutants RG2 and
with IFNg for 1 hr. Extracts were then mixed with 32P-labeled oligonu- d2±36. In each case, purified Stat1a was incubated with purified GST
cleotide probe containing the ICAM-1 gene IFNg-response element or GST-E1A-12S fusion proteins bound to glutathione-Sepharose
(IRE, nucleotides 2130 to 281, left panel) or an unrelated cAMP beads. Stat1 bound to E1A was analyzed by immunoblot analysis
response element (CRE, right panel) in gel mobility shift assays. using anti-Stat1 MAb (upper panel) and equivalent amounts of each
Arrows indicate the positions of constitutive Sp1 and IFNg-inducible GST or GST-E1A fusion protein were verified by Coomassie staining
Stat1 bound to the IRE probe (left panel) and the CRE-binding com- (lower panel).
plex (CRE-BC) bound to the CRE probe (right panel). (D) E1A-Stat1 interaction was assessed in a yeast two-hybrid system
with Stat1 fused to the LexA DNA-binding domain (LexA-BD) as bait
hybrid and E1A-12S fused to the VP16 activation domain (VP16-
AD) as prey hybrid. Interaction between hybrid proteins results inwas abolished by either Arg2 to Gly2 substitution (E1A-
transcriptional activation of the HIS3 and lacZ reporter genes and12S-RG2) or amino acids 2±36 deletion (E1A-12S-d2±36)
is first detected by selecting yeast prototrophic for histidine andof the E1A N terminus (Figure 4B). Since p300/CBP also
then quantified by a second screen for b-galactosidase activity.
binds Stat1, we also observed Stat1 in the immune com- Activity values are expressed as mean 6 SEM of independent trans-
plex precipitated by native E1A but not in one containing formations (n 5 3±6), and a significant increase from control level
is indicated by an asterisk.E1A-12S-d2±36. Unexpectedly, however, we also de-
tected Stat1 in a complex containing E1A-12S-RG2. This
finding indicated that E1A interaction with Stat1 does
Stat1 and Adenovirus
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not require p300/CBP. Specificity of these interactions at higher concentrations), while E1A-d2±36 lacked sig-
nificant blocking effect at any concentration.and modularity of E1A was confirmed by the fact that
these mutant E1A proteins maintained the capacity to In the second set of experiments, hTBE cells were
monitored for IFNg-inducible ICAM-1 gene expressioninteract with Rb protein that binds to the conserved
regions 1 and 2 of E1A without requiring the E1A N with or without infection with AdV expressing wild-type
or mutant E1A. In this system, we found that AdV ex-terminus (Wang et al., 1993).
To next determine whether Stat1 interacts directly pressing either wild-type E1A or E1A-RG2 markedly in-
hibited IFNg-driven, Stat1-dependent induction of ICAM-1with E1A without a requirement for other viral or cellular
proteins, we performed a second set of experiments mRNA levels, while AdV expressing E1A-d2±36 had no
significant effect on these levels (Figure 5B). In this case,using purified Stat1 and wild-type or mutant E1A pre-
sented as GST±fusion proteins on Sepharose beads. In as in the case of protein interaction and promoter trans-
activation experiments, the effect of E1A-RG2 wasresults similar to those of coimmunoprecipitation experi-
ments with endogenous proteins, we found that wild- slightly decreased from wild-type E1A. This difference
may reflect weaker interaction of E1A-Stat1 versus E1A-type E1A 12S and E1A-12S-RG2 but not E1A-12S-d2±36
bind to Stat1, while wild-type E1A but neither E1A-12S- p300/CBP or may be due to a partial requirement of
Arg2 for E1A-Stat1 interaction. Nonetheless, the resultsRG2 nor E1A-12S-d2±36 bind to p300/CBP (Figure 4C).
The selective loss of E1A-Stat1 interaction with E1A- for reporter and endogenous ICAM-1 gene expression
consistently indicate that E1A blockade of IFNg-induced12S-d2±36 versus E1A-12S-RG2 indicated that Stat1
binds to N-terminal determinants distinct from those for ICAM-1 promoter activity can be dissociated from E1A
interaction with p300/CBP and correlate closely withp300/CBP. Furthermore, the selective capacity of E1A-
12S-RG2 to bind Stat1 but not p300/CBP provided the E1A interaction with Stat1. Taken together, the results
suggest that E1A interaction with Stat1 as well as CBP/first evidence of a role for E1A in more specifically
blocking Stat1-dependent events via direct E1A-Stat1 p300 accounts for early-phase adenoviral inhibition of
IFNg-dependent gene expression (Figure 6).interaction.
To verify Stat1-E1A binding in an intracellular environ-
ment and to further assess the structural basis for inter-
Discussionaction, we used a yeast two-hybrid system with Stat1
linked to the LexA DNA-binding domain as bait hybrid
Defining adenoviral±host interactions in general, and ad-and 12S E1A linked to a nuclear-localized, VP16 acidic
enoviral E1A±host protein interactions in particular, hasactivation domain as prey hybrid (Vojtek et al., 1993).
proved extremely useful in defining the transcriptionalHybrid protein interaction was detected between E1A
pathways for controlling the cell cycle and the immuneand full-length Stat1 (Stat1a) but was not found with
response. For cell cycle, E1A targets Rb- and p300/E1A and the natural Stat1 splice variant (Stat1b) that
CBP-type proteins using distinct determinants from thelacks C-terminal amino acids 712±750 required for gene
N terminus, conserved region 1, and conserved regiontransactivation (Darnell, 1997) (Figure 4D). These find-
2 (Moran, 1994). The N terminus, at least to date, isings indicate that E1A efficiently targets the form of
restricted to interaction with p300/CBP-type proteins,Stat1 responsible for induction of gene transcription,
and this capacity is uniformly lost with RG2 or d2-36and this selection depends on interaction between the
mutations (Whyte et al., 1989; Wang et al., 1993; Lee etE1A N terminus and the Stat1 C terminus.
al., 1996). For immune response control, E1A may use
a similar strategy because p300/CBP is also a critical
regulator of IFN-driven, Stat1- and Stat2-dependent im-Mutant E1A that Interacts with Stat1 but Not
p300/CBP Blocks IFNg-Dependent mune events. In this case and others, E1A may compete
with endogenous p300/CBP and block STAT-dependentGene Transcription
As noted above, selective binding of E1A-RG2 to Stat1 gene expression (Bhattacharya et al., 1996; Zhang et
al., 1996; Horvai et al., 1997).but not p300/CBP provided a tool to determine the ca-
pacity of E1A-Stat1 interaction to inhibit IFNg-depen- The present results, however, indicate that Stat1-
dependent events may be targeted by several distinctdent gene activation. To examine this possibility, we
performed one set of experiments to assess E1A effects actions of E1A, including an interaction of the E1A N
terminus with Stat1 itself. Thus, in addition to targetingon Stat1-dependent activation of an ICAM-1 promoter
construct and a second set of experiments to assess p300/CBP, we find that distinct E1A determinants at the
N terminus also bind directly to Stat1 and consequentlyE1A action on the endogenous ICAM-1 gene expression
(in both cases using human airway epithelial cells). inhibit Stat1-dependent gene activation early in the
course of adenoviral infection. This early phase of infec-In the first set of experiments, hTBE cells were co-
transfected with a reporter plasmid containing ICAM-1 tion (i.e., the first 8±12 hr of infection that ends with viral
DNA synthesis and correlates with peak expression of59-flanking sequence from nucleotides 2130 to 235 (in-
cluding the IFNg-response element) driving a luciferase E1A) is therefore a critical time for avoidance of immune
detection. In addition to these early effects on Stat1gene and an expression plasmid encoding for wild-type
or mutant E1A. In this system, we found that expression action, we also find that E1A-dependent events lead
to downregulation of Stat1 phosphorylation later in theof both E1A 13S and 12S inhibited basal and IFNg-
induced promoter activity in a concentration-dependent course of infection. During the late phase (12±36 hr after
the initial infection, when adenoviral late genes L1±5fashion (Figure 5A). We also found that E1A-RG2 inhib-
ited IFNg-induced ICAM-1 promoter activity (particularly direct the assembly of new virus and shutdown of host
Immunity
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Figure 5. E1A-RG2 Inhibition of IFNg-Inducible Gene Transcription Assessed by ICAM-1 Promoter Activity and by Endogenous ICAM-1 Gene
Expression
(A) To detect the effect of E1A and E1A mutant expression on ICAM-1 promoter activity, transactivation assays were performed on hTBE cell
monolayers cotransfected with pBH-130±35ICAM-1-luc reporter plasmid and control or E1A expression plasmids encoding 13S E1A, 12S E1A,
12S E1A with RG2 substitution, or 12S E1A with d2-36 deletion. Cotransfected cells were either left untreated or treated with IFNg for 4 hr
and then assayed for luciferase activity. All values are the mean of duplicate samples and are representative of three experiments. Equivalent
expression of each E1A protein was verified by immunoblot analysis using anti-E1A MAb (data not shown).
(B) To detect effects of AdV expressing wild-type or mutant E1A on ICAM-1 gene expression, Northern blot analysis of ICAM-1 mRNA was
performed on monolayers that were uninfected (NV) or were infected with wild-type (WT) or E1A-RG2 or E1A-d2-36 mutant AdV for 8 hr and
then left untreated or treated with IFNg for 4 hr. Arrows indicate positions of ICAM-1 and GAPDH mRNA. Relative levels of mRNA were
quantitated by phosphorimaging (lower panel).
cell macromolecular synthesis), a decrease in Stat1 antiviral defense is underscored by the requirement for
Stat1 in host cell establishment of an IFN-dependentphosphorylation may reflect the general diversion of
host cell energy toward production of viral proteins. antiviral state in vitro and in vivo (Durbin et al., 1996;
Horvath and Darnell, 1996; Meraz et al., 1996). Conse-Therefore, adenoviral E1A has evolved three distinct
molecular mechanisms to disrupt Stat1-dependent im- quently, AdV capacity to block Stat1-dependent gene
activation by several distinct mechanisms is designedmunity, first by blocking transactivation at the promoter
and then by downregulating activation, presumably at to insure a productive viral infection. In fact, the inability
of E1A-deficient AdV to block Stat1-dependent genethe IFN receptor complex.
Adenoviral evolution toward multiple strategies to block expression may promote the inflammatory response
during gene therapy with adenoviral vectors, especiallyStat1 action likely reflects a critical requirement for
Stat1-dependent events in mucosal immunity to respira- since this response appears to depend on ICAM-1 ac-
tions (Guerette et al., 1997).tory (and other) viruses. Thus, Stat1 (in airway epithelial
and other cell types) is positioned as the trigger for The actions of E1A protein defined by our study of
primary culture cells stand in some contrast to previousan entire set of immune-response genes with antiviral
function. In addition to the ICAM-1 gene, functional Stat1 work that uses established cell lines. Thus, transformed
cell lines with stable E1A expression exhibit reduced(and adjacent Sp1) sites are found in the gene regulatory
regions for IRF-1, transporter associated with antigen IFNg-driven gene expression that correlates with de-
creased formation of DNA-binding complexes (Ackrill etprocessing-1 (TAP-1), and perhaps Stat1 itself (Sims et
al., 1993; Min et al., 1996). In addition, the IRF-1 gene al., 1991; Kalvakolanu et al., 1991; Leonard and Sen,
1996), and this mechanism presumably underlies E1Aproduct (in concert with other factors) is responsible for
activating the genes for MHC class I molecules, induc- action on ICAM-1 gene expression in A549 cells (Keicho
et al., 1997). As noted above, this action of E1A is notible nitric oxide synthase (i-NOS), and IFNa/b (Fujita et
al., 1988; Girdlestone et al., 1993; Kamijo et al., 1994). observed during early-phase adenoviral infection and is
found only in late-phase infection. However, even in theIn turn, Stat1 is required for mediating the antiviral re-
sponse triggered by IFNa/b (Darnell, 1997). case of more prolonged expression, E1A effects in some
cell lines appear to depend on a decrease in cellularThus, a cascade of common molecular building blocks
enables IFNg to efficiently and selectively activate genes Stat1 levels (Leonard and Sen, 1996), and this effect
is not observed during early- or late-phase adenoviraloriented toward several levels of anti-viral defense: anti-
gen recognition and T cell costimulation as well as im- infection in the natural host cell. Taken together, the
results indicate that transformed cell lines with stablemune cell recruitment (ICAM-1), antigen processing
(TAP-1), and amplification of the immune response expression of E1A may reflect conditions with prolonged
or chronic viral infection or persistent viral remnants(Stat1 and IRF-1) with additional capacity for antigen
recognition (MHC class I) and antiviral toxicity (i-NOS but may not be accurate models of initial adenoviral
infection at least in airway epithelium.and IFNa/b). The critical nature of Stat1 signaling for
Stat1 and Adenovirus
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allow for determining relative contribution to adenoviral
suppression of IFNg-inducible gene expression. The pres-
ent results already provide an appropriate E1A-medi-
ated strategy for more selectively downregulating Stat1-
dependent immunity in the airway.
Experimental Procedures
Airway Epithelial Cell Isolation, Culture, and Stimulation
Human tracheobronchial epithelial (hTBE) cells were isolated from
tracheal and bronchial mucosal strips by enzymatic dissociation
and cultured in Laboratory of Human Carcinogenesis (LHC)-8e me-
dium on flasks coated with collagen/albumin for study up to passage
10 as described previously (Look et al., 1992). Cells were treated
with recombinant IFNg (Genentech, San Francisco, CA) at a concen-
tration (100 U/ml) and for durations that resulted in maximal effects
on Stat1 phosphorylation, nuclear translocation, DNA binding (1 hr),
ICAM-1 gene transcription (3 hr), and ICAM-1 mRNA (4 hr) and
protein or adhesion (18 hr) levels (Look et al., 1992, 1994; Nakajima
et al., 1994; Walter et al., 1997).
Adenovirus Preparation and Infection
Wild-type adenovirus 5 (AdV) and an E1A-deficient mutant (AdV-
d312) were gifts from S. Brody (Washington University). Adenovirus
expressing the 12S splice-variant of E1A without mutation (AdV-
12S.WT) or with Arg2 to Gly2 substitution (AdV-12S.RG2) or amino
acids 2±36 deletion (AdV-12S.d2±36) were gifts from E. Moran (Tem-
ple University) (Wang et al., 1993). Adenoviruses were propagated
in human 293 cells (CRL 1573, American Type Culture Collection)
that were grown in Dulbecco's modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum, 2 mM glutamine, 100
U/ml penicillin, 100 mg/ml streptomycin, and 0.25 mg/ml amphoteri-
cin B at 378C in 5% CO2. Cell cultures were infected in DMEM without
supplements for 36 hr when cytopathic effect was evident in .90%Figure 6. Model for DNA±Protein and Protein±Protein Interactions
of cells. Virus was released from cells by freeze-thaw disruption, andthat Control the Transcription Rate of the ICAM-1 Gene
crude viral lysates were purified by centrifugation through cesium(A) Under basal conditions, Sp1 binds to the GC-box at nucleotides
chloride; desalted using a PD-10 column (Pharmacia Biotech, Pis-299 to 294 and interacts with the PolII-specific basal transcription
cataway, NJ) into a storage buffer consisting of 137 mM NaCl, 5complex that binds at the TATA box and initiates transcription at
mM KCl, 25 mM Tris-HCl, 0.7 mM phosphate buffer (pH 7.4), andthe transcription initiation site (TIS).
10% glycerol; and then frozen at 2708C. Titer of viral stocks was(B) Under IFNg-stimulated conditions, phosphorylated Stat1 dimer
determined by plaque assay on 293 cell monolayers as describedbinds to the inverted-repeat (IR) at nucleotides 2106 to 106 and
previously (Graham and Prevec, 1991), and particle (as measuredinteracts with Sp1 and p300/CBP, which in turn interact with the
by OD260) to plaque-forming units (PFU) ratios of viral preparationsbasal complex (for p300/CBP interaction occurs via p/CIP).
were 10 to 100. Based on preliminary studies that established the(C) During early adenoviral infection, E1A disrupts transcriptional
multiplicity of infection (MOI) resulting in infection of $98% of cells,initiation by direct interactions with Stat1 (1) and with p300/CBP (2).
adenovirus were incubated with hTBE cells for 2±28 hr in LHC-8e
media at 378C in 5% CO2 using an MOI of 3 PFU/cell.
In summary, our results indicate that E1A-mediated Target Protein, mRNA, and Transcription Levels
ICAM-1 and MHC class I levels on the cell surface were determinedsuppression of host defense is appropriately aimed at
by enzyme-linked immunoassay using anti-ICAM-1 MAb 84H10 andIFNg-driven, Stat1-dependent gene activation and is di-
anti-HLA-A,B MAb W6/32 as described previously (Look et al., 1992).rected toward inhibition of Stat1 activation, Stat1 inter-
ICAM-1-dependent T cell adhesion to hTBE cell monolayers wasaction with p300/CBP, and a novel inhibitory interaction
determined by a quantitative flow cytometry±based assay as de-
between the E1A N terminus and the Stat1 transcription scribed previously (Nakajima et al., 1994, 1995; Taguchi et al., 1998).
factor. The results provide for a distinct activity of the ICAM-1 and IRF-1 mRNA levels were determined by Northern blot
analysis as described previously (Look et al., 1992) using the 1.4E1A N terminus and call for a revised model for Stat1-
kb XhoI fragment from pCD1.8 containing human ICAM-1 cDNAdependent gene activation. Previous models provided
(Staunton et al., 1989), 2.0 kb EcoRI fragment from pUCIRF-1 con-for Stat1 contact with the basal transcription complex
taining human IRF-1 cDNA (Sims et al., 1993), and as control, the 0.55via Sp1 or p300/CBP. However, the E1A N terminus does
kb XbaI±HindIII fragment from pHcGAP containing human GAPDH
not directly or indirectly interact with Sp1 (Liu and Green, cDNA (Look et al., 1994). Gene transcription rates for ICAM-1, IRF-1,
1994; Moran, 1994; Horvai et al., 1997) and does not and controls were determined using nuclear runoff assay as de-
scribed previously (Look et al., 1994). Control cDNA probes includedneed to interact with p300 to block Stat1 transactivation
human b1-integrin cDNA in pGEM-1 (from plP32, E. Ruoslahti, La-(present results). The findings imply that E1A N-terminal
Jolla Cancer Research Foundation), human skeletal a-actin cDNAbinding to Stat1 impairs Stat1 interaction with other
encoding amino acids 202±374 in pBR322 (pHMaA-PX, P. Gunning,adaptor proteins (in addition to p300/CBP) that may be
Children's Medical Research Institute, Wentworthville, NSW, Austra-
necessary to link Stat1 to the basal complex. Identifica- lia), AdV type 2 E1A 13S and 12S cDNA in pBluescriptSK (pE1A13S
tion and mutation of E1A N-terminal residues that are and pE1A12S, S. Weintraub, Washington University) (Weintraub and
Dean, 1992), human thyroid transcription factor-1 (TTF-1) cDNA inneeded for Stat1 (but not p300/CBP) interaction will
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pRcCMV (pCMV-TTF1, R. Di Lauro, Stazione Zoologica, Naples, LexA binding sites. Interaction between hybrid proteins was there-
fore detected by selection on solid medium lacking histidine andItaly), human RelA/p65 and Rel/c-Rel cDNA in pCMV4 (pC4-p65 and
pC4-c-rel, W. Greene, University of California-San Francisco), and then was quantified by assay of b-galactosidase activity in liquid
cultures as described previously (Miller, 1972).Alu repetitive sequence cDNA in pBluescriptSK (pSKAlu, T. Ley,
Washington University).
Luciferase Reporter Gene Transactivation Assay
E1A expression plasmids were generated using PCR amplificationStat1 Phosphorylation, Translocation,
with pE1A13S or pE1A12S as DNA template, a downstream primerand DNA-Binding Assays
containing a NotI restriction site and nucleotides encoding a stopStat1 phosphorylation was monitored by immunoblotting with anti-
codon and the C terminus of E1A, and upstream primers containingStat1 MAb (Transduction Laboratories, Lexington, KY) as described
a XhoI site and nucleotides encoding the N terminus of E1A withoutpreviously (Walter et al., 1997), except that membranes were also
or with mutation. PCR products were generated using Thermusreprobed with anti-E1A MAb (M73; Oncogene Science, Cambridge,
flavus DNA polymerase (Amersham International) and a 558C anneal-MA) after washing in 62.5 mM Tris (pH 6.8), 2% SDS, and 100 mM
ing cycle, digested with NotI and XhoI, and ligated into NotI/XhoI-b-mercaptoethanol at 658C for 30 min. Stat1 translocation was moni-
digested pCI-neo (Promega, Madison, WI) to generate pCI-E1A13S,tored by immunofluorescent microscopy using anti-Stat1 antisera
pCI-E1A12S, pCI-E1A12S.RG2, and pCI-E1A12S.d2-36. Insert orien-(1:300, vol/vol) as described previously (Walter et al., 1997). Stat1
tation and sequence integrity were verified by DNA sequencing.was localized to AdV-infected cells using anti-E1A MAb (1 mg/ml).
Expression level of plasmid constructs after transient transfectionStat1 binding to DNA was monitored by gel mobility shift assay
into hTBE cells was verified using immunoblot analysis. The con-using the ICAM-1 gene IFNg-response element (IRE, nucleotides
struction of the reporter plasmid containing the Photinus pyralis2130 to 281) as described previously (Look et al., 1994, 1995).
luciferase gene driven by ICAM-1 gene 59-flanking sequence fromEquivalency of protein isolation between samples was verified using
nucleotides 2130 to 235 (pBH-130-35ICAM-1-luc) has been de-protein binding to an unrelated cAMP response element (CRE) (Look
scribed previously (Look et al., 1994).et al., 1994) that is unaffected by IFNg treatment or adenoviral in-
Plasmid DNA was purified and then used to transfect duplicatefection.
hTBE cell monolayers using a liposomal DNA packaging system as
described previously (Look et al., 1994, 1995; Walter et al., 1997).
Immunoprecipitation and Protein Interaction Assays
In the present study, each monolayer (in a 35 mm culture plate) was
Cellular proteins were extracted using 50 mm Tris (pH 8), 250 mM
treated with 1 ml of antibiotic-free medium containing 2 mg of pBH-
NaCl, 0.2% Nonidet P-40, 1 mm EDTA, 1 mM DTT, 1 mM orthovana-
130-35ICAM-1-luc with varying amounts of control or E1A expres-
date, 10 mM sodium fluoride, 2 mM sodium pyrophosphate, 1 mM
sion plasmid and 12 mg of GeneFECTOR reagent (VennNova, Miami,
PMSF, 20 mM leupeptin, and 1 mM aprotinin. Extract (with 1 mg of
FL) for 16 hr at 378C, washed with complete media containing 0.5%
protein) was incubated with 5 mg of anti-E1A MAb in 500 ml lysis
BSA, and then treated with 1 ml of complete media with or without
solution (150 mM NaCl and 0.1% Nonidet P-40) for 16 hr at 48C.
IFNg for 4 hr at 378C. Luciferase activity was determined from cell
Immune complexes were precipitated using protein A-Sepharose
lysates as described previously (Look et al., 1994). In some experi-
beads (Pharmacia Biotech) and were subjected to immunoblotting
ments, reporter and expression plasmids were cotransfected with
as noted above using anti-Stat1 MAb and controls that included
5 ng of pRL-SV40, and Renilla reniformis luciferase activity was
anti-E1A MAb, rabbit antisera against Sp1 (PEP2, Santa Cruz Bio-
determined as described by the manufacturer (Promega) to control
technology, Santa Cruz, CA), and murine MAbs against p300 and
for transfection efficiency. In this system, IFNg causes no significant
retinoblastoma (Rb) protein (NM11 and G3±245, Pharmingen, San
effect on reporter gene activity for transfected control plasmids
Diego, CA). To assess interactions between purified proteins, re-
(Look et al., 1994). All results are the average of duplicate samples
combinant activated Stat1a was obtained from J. Darnell, Jr.,
and are representative of at least three separate experiments.
Rockefeller University (Vinkemeier et al., 1996). To prepare E1A,
expression plasmids for E1A 12S (without or with mutation) linked
Statistical Analysisto Schistosoma japonicum glutathione S-transferase (GST) were
Values for T cell adhesion, ICAM-1 levels, and yeast two-hybridgenerated by subcloning E1A12S, E1A12S.RG2, and E1A12S.d2±36
assays were analyzed using a one-way analysis of variance for a fac-cDNA (described below) into NotI/XhoI-digested pGEX-4T-1 (Phar-
torial experimental design. A P value of less than 0.05 was consid-macia Biotech). GST and GST-E1A expression plasmids were used
ered to indicate statistical significance. If significance was achievedto transform E. coli and fusion protein synthesis was induced with
by this analysis, post-ANOVA comparison of means was performed0.1 mM isopropyl b-D-thiogalactopyranoside for 2 hr at 258C. Protein
using Scheffe F tests.was released from bacteria by sonication in 50 mM HEPES (pH 7.2),
250 mM NaCl, 0.1% NP-40, 5 mM EDTA, 2 mM DTT, 1 mM PMSF,
1 mM leupeptin, and 1 mM pepstatin and then immobilized and Acknowledgments
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